• Rosana LazzariniEmail author
  • Mariana de Figueiredo Silva Hafner
  • Vanessa Barreto Rocha
  • Daniel Lorenzini


Eczemas are common in dermatologic practice. There are differing types such as contact dermatitis, atopic dermatitis, dyshidrotic, nummular, and stasis eczemas. The differential diagnosis is essential for appropriate treatment. This chapter describes the differences between the various forms of eczema and how they are treated.


Eczema Dermatitis Contact Allergic contact dermatitis Patch test Neurodermatitis Eczema infantile Vesicular palmoplantar Pompholyx 


  1. 1.
    Tan CH, Rasool S, Johnston GA. Contact dermatitis: allergic and irritant. Clin Dermatol. 2014;32(1):116–24.PubMedCrossRefGoogle Scholar
  2. 2.
    Belda Junior W, Chiacchio Di N, Criado PR. Tratado de Dermatologia. 2nd ed. São Paulo: Editora Atheneu; 2014.Google Scholar
  3. 3.
    Boonchai W, Thanomkitti K, Kasemsarn P. Occupational contact dermatitis in tertiary university hospital: a 5-year retrospective study. J Med Assoc Thail. 2014;97(11):1182–8.Google Scholar
  4. 4.
    Lurati AR. Occupational risk assessment and irritant contact dermatitis. Work Health Saf. 2015;63(2):81–7. quiz 88CrossRefGoogle Scholar
  5. 5.
    Cohen D, de Souza A. Irritant Contact Dermatitis. In Bolognia JL, Jorizzo JL, Schaaffer JV. Dermatologia. 3rd ed. Rio de Janeiro: Elsevier; 2012.Google Scholar
  6. 6.
    Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediat Inflamm. 2013;2013:916497.Google Scholar
  7. 7.
    Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol. 2002;27:138.PubMedCrossRefGoogle Scholar
  8. 8.
    Tovar R, Leikin JB. Irritants and corrosives. Emerg Med Clin North Am. 2015;33(1):117–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Coughlin CC, Eichenfield LF, Frieden IJ. Diaper dermatitis: clinical characteristics and differential diagnosis. Pediatr Dermatol. 2014;31(Suppl 1):19–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Klunk C1, Domingues E2, Wiss K3. An update on diaper dermatitis. Clin Dermatol. 2014;32(4):477–87.PubMedCrossRefGoogle Scholar
  11. 11.
    Blume-Peytavi U1, Hauser M, Lünnemann L, Stamatas GN, Kottner J, Garcia BN. Prevention of diaper dermatitis in infants – a literature review. Pediatr Dermatol. 2014;31(4):413–29.Google Scholar
  12. 12.
    Ravanfar P, Wallace JS, Pace NC. Diaper dermatitis: a review and update. Curr Opin Pediatr. 2012;24(4):472–9.PubMedGoogle Scholar
  13. 13.
    Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, Gonçalo M, Goossens A, Le Coz CJ, Rustemeyer T, White IR, Agner T. European Environmental and Contact Dermatitis Research Group. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160(2):353–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population – prevalence and main findings. Contact Dermatitis. 2010;62(2):75–87.Google Scholar
  15. 15.
    Behroozy A, Keegel TG. Wet-work exposure: a main risk factor for occupational hand dermatitis. Saf Health Work. 2014;5(4):175–80.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Meding B, Anveden Berglind I, Alderling M, Lindahl G, Wrangsjö K. Water exposure – challenging differences between occupations. Contact Dermatitis. 2016;74(1):22–8.Google Scholar
  17. 17.
    León FJ, Berbegal L, Silvestre JF. Management of chronic hand eczema. Actas Dermosifiliogr. 2015;106(7):533–44.PubMedCrossRefGoogle Scholar
  18. 18.
    Bubna AK. Alitretinoin in dermatology-an update. Indian J Dermatol. 2015;60(5):520.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Choi JM, Lee JY, Cho BK. Chronic irritant contact dermatitis: recovery time in man. Contact Dermatitis. 2000;42:26.CrossRefGoogle Scholar
  20. 20.
    Kutlubay Z, Sevim A, Engin B, Tüzün Y. Photodermatoses, including phototoxic and photoallergic reactions (internal and external). Clin Dermatol. 2014;32:73–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Choi D, Kannan S, Lim HS. Evaluation of patients with photodermatoses. Dermatol Clin. 2014;32(3):267–75.PubMedCrossRefGoogle Scholar
  22. 22.
    Rietschel RL. Clues to an accurate diagnosis of contact dermatitis. Dermatol Ther. 2004;17(3):224.Google Scholar
  23. 23.
    Rietschel R, Fowler J. Fisher’s contact dermatitis. 6th ed. Hamilton: BC Decker; 2008.Google Scholar
  24. 24.
    COMMISSION E. Opinion on fragrance allergens in cosmetic products. 2012. Disponível em: Acesso em: 24 maio 2014.
  25. 25.
    Mowad C, Marks JR, J. Allergic contact dermatitis. In: Bolognia J, Jorizzo J, et al., editors. Dermatology. v.01; 2012. Mosby Elsevier, Rio de Janeiro.Google Scholar
  26. 26.
    Lopes LR, Kundman D, Duarte I. Avaliação da frequência de dermatoses no serviço ambulatorial de dermatologia. An Bras Dermatol. 2010;85(2):264–6.PubMedCrossRefGoogle Scholar
  27. 27.
    SBD. Perfil nosológico das consultas dermatológicas no Brasil. An Bras Dermatol. 2006;81(6):549–58.CrossRefGoogle Scholar
  28. 28.
    Duarte I, Cunha J, Lazzarini R. Allergic contact dermatitis in private practice: what are the main sensitizers? Dermatitis. 2011;22(4):225–6. ISSN 1710–3568. Disponível em: Scholar
  29. 29.
    Dinkloh A, et al. Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006–2011. J Eur Acad Dermatol Venereol. 2014. ISSN 1468–3083. Disponível em:
  30. 30.
    Brandão MH, Gontijo B. Contact sensitivity to metals (chromium, cobalt and nickel) in childhood. An Bras Dermatol. 2012;87(2):269–76. ISSN 1806–4841. Disponível em: Scholar
  31. 31.
    Machovcova A, et al. Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*. Contact Dermatitis. 2005;53(3):162–6. ISSN 0105–1873. Disponível em: Scholar
  32. 32.
    Warshaw EM, et al. North American Contact Dermatitis Group patch-test results, 2003–2004 study period. Dermatitis. 2008;19(3):129–36. ISSN 1710–3568. Disponível em: Scholar
  33. 33.
    Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirvas MJ et al. North American contact dermatitis group patch test results: 2011–2012. Dermatitis. 2015;26(1):49–59. ISSN 2162–5220. Disponível em:
  34. 34.
    Rodrigues DF, Goulart EM. Patch test results in children and adolescents. Study from the Santa Casa de Belo Horizonte Dermatology Clinic, Brazil, from 2003 to 2010. An Bras Dermatol. 2015;90(5):671–83. ISSN 1806–4841. Disponível em: Scholar
  35. 35.
    Goldenberg A, et al. Nickel allergy in adults in the U.S.: 1962 to 2015. Dermatitis. 2015;26(5):216–23. ISSN 2162–5220. Disponível em: Scholar
  36. 36.
    Zug KA, et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55. ISSN 2162–5220. Disponível em: Scholar
  37. 37.
    Duarte I, Kobata C, Lazzarini R. Dermatite de contato em idosos. An Bras de Dermatol. 2007;82(2):135–40.CrossRefGoogle Scholar
  38. 38.
    Martin SF. New concepts in cutaneous allergy. Contact Dermatitis. 2015;72(1):2–10. ISSN 1600–0536. Disponível em: Scholar
  39. 39.
    Scherrer MA, Rocha VB. Increasing trend of sensitization to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI). An Bras Dermatol. 2014;89(3):527. ISSN 1806–4841. Disponível em: Scholar
  40. 40.
    Lammintausta K, et al. An epidemic of contact allergy to methylisothiazolinone in Finland. Contact Dermatitis. 2014;70(3):184–5. ISSN 1600–0536. Disponível em: Scholar
  41. 41.
    Gameiro A, et al. Methylisothiazolinone: second ‘epidemic’ of isothiazolinone sensitization. Contact Dermatitis. 2014;70(4):242–3. ISSN 1600–0536. Disponível em: Scholar
  42. 42.
    Bruze M, et al. Recommendation to include methylisothiazolinone in the European baseline patch test series-on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis. 2013;69(5):263–70. ISSN 1600–0536. Disponível em: Scholar
  43. 43.
    Johnston, G. A.; (BSCA), C. M. O. T. B. S. F. C. A. The rise in prevalence of contact allergy to methylisothiazolinone in the British Isles. Contact Dermatitis, 70, 4, 238–240, 2014. ISSN 1600–0536. Disponível em:
  44. 44.
    Uter W, et al. Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis. 2013;69(4):231–8. ISSN 1600–0536. Disponível em: Scholar
  45. 45.
    Castanedo-Tardana MP, Zug KA. Methylisothiazolinone. Dermatitis. 2013;24(1):2–6. ISSN 2162–5220. Disponível em: Scholar
  46. 46.
    Duarte I, et al. Dermatite de Contato. An Bras de Dermatol. 2000;75(5):529–48.Google Scholar
  47. 47.
    Martins LEAM, Reis VMS. Imunopatologia da dermatite de contato alérgica. An Bras Dermatol. 2011;86(3):419–33.PubMedCrossRefGoogle Scholar
  48. 48.
    Lazzarini R, Duarte I, Ferreira A. Testes de contato. An Bras Dermatol. 2013;88(6):879–89.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Johansen J, Frosh P, Lepoittevin J. Contact Dermatitis. 5th ed. Berlin: Springer; 2010.Google Scholar
  50. 50.
    Cohen D, Jacob S. Allergic contact dermatitis. In: Wolff K, Goldsmith LA, Katz S, et al., editors. Fitzpatrick’s dermatology in general medicine, vol. 1. 7th ed. New York: MCGraw Hill; 2008.Google Scholar
  51. 51.
    Benezra C, Maibach H. True cross-sensitization, false cross-sensitization and otherwise. Contact Dermatitis. 1984;11(2):65–9. ISSN 0105–1873. Disponível em: Scholar
  52. 52.
    Sampaio S, Rivitti E. Dermatologia. 3rd ed. São Paulo: Artes Médicas; 2008.Google Scholar
  53. 53.
    Azulay R, Azulay D, Azulay-Abulafia L. Dermatologia. 6a ed. Rio de Janeiro: Guanabara Koogan; 2013.Google Scholar
  54. 54.
    Heisterberg MV, et al. Deodorants are the leading cause of allergic contact dermatitis to fragrance ingredients. Contact Dermatitis. 2011;64(5):258–64. ISSN 1600–0536. Disponível em: Scholar
  55. 55.
    Bregnbak D, et al. Chromium allergy and dermatitis: prevalence and main findings. Contact Dermatitis. 2015;73(5):261–80. ISSN 1600–0536. Disponível em: Scholar
  56. 56.
    Lazzarini R, et al. Allergic contact dermatitis among construction workers detected in a clinic that did not specialize in occupational dermatitis. An Bras Dermatol. 2012;87(4):567–71. ISSN 1806–4841. Disponível em: Scholar
  57. 57.
    Agarwal US, et al. Hand eczema. Indian J Dermatol. 2014;59(3):213–24. ISSN 1998–3611. Disponível em: Scholar
  58. 58.
    Belda W Jr, Di Chiacchio N, Criado P. Tratado de Dermatologia. 2nd ed. Rio de Janeiro: Atheneu; 2014.Google Scholar
  59. 59.
    Goh C. Noneczematous occupational contact reactions. In: Rustemeyer TEP, John S, et al., editors. Kanerva’s occupational dermatology, vol. 1. New York: Springer; 2012.Google Scholar
  60. 60.
    Mowad C, Markes J Jr. Allergic contact dermatitis. In: Bologna J, Jorizzo J, et al., editors. Dermatology, vol. 1. 2nd ed. Spain: Mosby-Elsevier; 2008.Google Scholar
  61. 61.
    Flyvholm MA. Preservatives in registered chemical products. Contact Dermatitis. 2005;53(1):27–32. ISSN 0105–1873. Disponível em: Scholar
  62. 62.
    Grupo Brasileiro De Estudo Em Dermatite De Contato, G. Estudo multicêntrico para elaboração de uma bateria-padrão brasileira de teste de contato. An Bras Dermatol. 2000;75(2):147–56.Google Scholar
  63. 63.
    Timm-Knudson VL, et al. Allergic contact dermatitis to preservatives. Dermatol Nurs. 2006;18(2):130–6. ISSN 1060–3441. Disponível em: Scholar
  64. 64.
    Yiannias J, El-Azhary R. Contact allergen avoidance program: topical skin care product database. Am J Contact Dermatitis. 2000;11(4):243–7.PubMedCrossRefGoogle Scholar
  65. 65.
    El-Azhary R, Yiannias J. A new patient education approach in contact allergic dermatitis: the Contact Allergen Replacement Database (CARD). Int J Dermatol. 2004;43(4):278–80.PubMedCrossRefGoogle Scholar
  66. 66.
    Alani JI, Davis MD, Yiannias JA. Allergy to cosmetics: a literature review. Dermatitis. 2013;24(6):283–90. ISSN 1710–3568. Disponível em: Scholar
  67. 67.
    Kist J, Yiannias J, El-Azhary R. Efficacy of contact allergen replacement database (CARD) in the treatment of allergic contact dermatitis secondary to topical skin care product use (American Contact Dermatitis Society Annual Meeting Abstracts – oral presentation). Am J Contact Dermatitis. 2001;12(2):124.Google Scholar
  68. 68.
    Greenspoon J, Ahluwalia R, Juma N, Rose CF. Dermatitis. 2013;24(1):29–32.PubMedCrossRefGoogle Scholar
  69. 69.
    Kutlubay Z, Sevim A, Engin B, Tuzun Y. Clin Dermatol. 2014;32:73–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Hanifin JM, Rajka RG. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(Suppl):44–7.Google Scholar
  71. 71.
    Laughter D, Istvan JA, Tofte SJ, Hanifin JH. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000;43:649–55.PubMedCrossRefGoogle Scholar
  72. 72.
    Scultz-Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol. 1996;34:760–4.CrossRefGoogle Scholar
  73. 73.
    McNally NJ, Williams HC, Phillips DR. Atopic eczema and the home environment. Br J Dermatol. 2001;145:730–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Williams HC. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–66.PubMedCrossRefGoogle Scholar
  75. 75.
    Lowe AJ, Carlin JB, Bennett CM, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol. 2008;121(5):1190–5.PubMedCrossRefGoogle Scholar
  76. 76.
    Wadonda-Kabondo N, Sterne JA, Golding J, Kennedy CT, Archer CB, Dunnill MG, et al. Association of parental eczema, hayfever and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child. 2004;89:917–21.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365:1315–27.PubMedCrossRefGoogle Scholar
  78. 78.
    Madison K. Barrier function of the skin: “La Raison d’Etre” of the epidermis. J Invest Dermatol. 2003;121:231–41.PubMedCrossRefGoogle Scholar
  79. 79.
    Proksch E, Jensen J-M, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Derm. 2003;21:134–4.Google Scholar
  80. 80.
    Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59:561–70.PubMedCrossRefGoogle Scholar
  81. 81.
    Elsner J, Kapp A. Regulation and modulation of eosinophil effector functions. Allergy. 1999;54:15–26.PubMedCrossRefGoogle Scholar
  82. 82.
    Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112:S128–39.PubMedCrossRefGoogle Scholar
  83. 83.
    Leung DYM, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993;92:1374–80.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Scalabrin DMF, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TAE, Wheatley LM. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol. 1999;104:1273–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Clark RAF, Adinoff AD. Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool. J Am Acad Dermatol. 1989;21:863–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Mrohashi M. Never growth factor and substance P are useful plasma markers of disease activity in atopic dermatites. Br J Dermatol. 2002;147:71–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines”. J Am Acad Dermatol. 2004;50:391–404.PubMedCrossRefGoogle Scholar
  88. 88.
    Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy Article ID354250, 7 pages.Google Scholar
  89. 89.
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001;107:891–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Vicenzi C, Revisi P, Guerra L. Patch testing with whole dust mite bodies in atopic dermatitis. Am J Contact Dermatitis. 1994;5:213–5.Google Scholar
  91. 91.
    Breternitz M, Kowatzki D, Langenauer M, Elsner P, Fliuhr JW. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation. Skin Pharmacol Physiol. 2008;21:39–45.PubMedCrossRefGoogle Scholar
  92. 92.
    Gutman AB, Kligman AM, Sciacca J, James WD. Soak and smear: a standard technique revisited. Arch Dermatol. 2005;141:556–9.CrossRefGoogle Scholar
  93. 93.
    Schnopp C, Holtmann C, Stock S, Remling R, Folster-Holst R, Ring J, et al. Topical steroids under wet-wrap dressing in atopic dermatitis – a vehicle-controlled trial. Dermatology. 2002;204:56–9.Google Scholar
  94. 94.
    Boguniewicz M. Topical treatment of atopic dermatitis. Immunol Allergy Clin N Am. 2004;24:631–44.CrossRefGoogle Scholar
  95. 95.
    El-Batawy MMY, Bosseila MAW, Mashaly HM, Hafez VSGA. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. J Derm Sci. 2009;54(2):76–87.CrossRefGoogle Scholar
  96. 96.
    Remitz A, Kyllonen H, Granlund H, Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol. 2001;107:196–7.PubMedCrossRefGoogle Scholar
  97. 97.
    Tennis P, Gelfand JM, Rothman KJ. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol. 2011;165:465–73.PubMedCrossRefGoogle Scholar
  98. 98.
    Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed. 2007;23:106–12.PubMedCrossRefGoogle Scholar
  99. 99.
    Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21:606–19.Google Scholar
  100. 100.
    Berth-Jones J, Takwale A, Tan E, Barclay G, Agarwal S, Ashmed I, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo controlled, crossover trial. Br J Dermatol. 2002;147:324–30.PubMedCrossRefGoogle Scholar
  101. 101.
    Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ. An open-label, doseranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol. 2007;156:346–51.PubMedCrossRefGoogle Scholar
  102. 102.
    Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an update Cochrane review. Br J Dermatol. 2010;163:12–26.PubMedCrossRefGoogle Scholar
  103. 103.
    Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics. 2011;128:1161–7.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin N Am. 2006;90:149–67.PubMedCrossRefGoogle Scholar
  105. 105.
    Schmitt J, Schakel K, Folster-Holst R, Bauer A, Oertel R, Augustin M, et al. Prednisolone vs cyclosporin for severe adult eczema: an investigator-initiated double-blind placebo-controlled multicenter trial. Br J Dermatol. 2010;162:661.PubMedCrossRefGoogle Scholar
  106. 106.
    Takaoka R, Aoki V, Campos TCC. Support groups for patients with atopic dermatitis: a nine-year experience. Dermatol Psychosom. 2000;1:33–8.Google Scholar
  107. 107.
    Weber MB, Lorenzini D, Reinehr CP, Lovato B. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol. 2012;87(5):697–702.PubMedCrossRefGoogle Scholar
  108. 108.
    Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol. 2012;31:36–42.Google Scholar
  109. 109.
    Bruno MCTC, Vilela MAC, Oliveira CABM. Estudo das dermatoses e sua prevalência em indivíduos comprovadamente alcoolistas comparados a um grupo de indivíduos não alcoolistas. An Bras Dermatol. 2013;88(3):373–80.CrossRefGoogle Scholar
  110. 110.
    Kim WJ, Ko HC, Kim MB, Kim JM, Kim BS. Features of Staphylococus aureus colonization in patients with nummular eczema. B J Dermatol. 2013;168:656–82.CrossRefGoogle Scholar
  111. 111.
    Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon alfa-2b and ribavirin combination therapy for hepatitis C infection. Arch Dermatol. 2005;14:102–3.Google Scholar
  112. 112.
    Sedie AD, Bazzichi L, Bombardieri S, Riente L. Psoriasis, erythema nodosum, and eczema numular onset in an ankylosing patient treated with infliximab. Scan J Reumatol. 2007;36(5):U14–404.Google Scholar
  113. 113.
    Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. Nummular eczema and contact allergy: a retrospective study. Dermatitis. 2012;23(4):153–7.PubMedCrossRefGoogle Scholar
  114. 114.
    Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics. Part II. Conditions that simulate lower limb cellulitis. J Am Acad Dermatol. 2012;67(2):177e1–9.Google Scholar
  115. 115.
    Miani S, Boneschi M, La Penna A, Giordanergo F. Fisiopatologoia della stasi venosa a livello del microcircolo. Minerva Cardioangiol. 1992;40:413–6.PubMedGoogle Scholar
  116. 116.
    Vary JC, O’Connor KM. Common dermatologic conditions. Med Clin N Am. 2014;98:445–85.PubMedCrossRefGoogle Scholar
  117. 117.
    Minelli L, Florião RA, Sternick M, Gon AS. Disidrose: aspectos clínicos, etiopatogênicos e terapêuticos. An Bras Dermatol. 2008;83(2):107–15.CrossRefGoogle Scholar
  118. 118.
    Logfren SM, Warshaw EM. Dermatitis. 2006;17(4):165–81.CrossRefGoogle Scholar
  119. 119.
    Chen JJ, Liang YH, Zhou FS, et al. The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1–18q22.3. J Invest Dermatol. 2006;126(2):300–4.PubMedCrossRefGoogle Scholar
  120. 120.
    Wollina U. Pompholyx. Review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(6):306–14.Google Scholar
  121. 121.
    Soler DC, Bai X, Ortega L, Pethukova T, Nedorost ST, Popkin DL, Cooper KD, Mc Cormick TS. The key of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx. Med Hypotheses. 2015;84:498–503.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Rosana Lazzarini
    • 1
    Email author
  • Mariana de Figueiredo Silva Hafner
    • 2
  • Vanessa Barreto Rocha
    • 3
  • Daniel Lorenzini
    • 4
  1. 1.Santa Casa de São Paulo School of Medical Sciences – School of MedicineSão PauloBrazil
  2. 2.Santa Casa de São Paulo HospitalSão PauloBrazil
  3. 3.Federal University of Minas Gerais Clinical HospitalBelo HorizonteBrazil
  4. 4.Federal University of Health Sciences from Porto Alegre – School of MedicinePorto AlegreBrazil

Personalised recommendations